MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Shire to acquire FerroKin BioSciences, Inc., and its Phase 2 iron chelator treatment.
Brennan CaruthersMarch 15, 2012
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Pronota Strengthens Management Team Former VP Corporate Development Genzyme joins as CBO.

Brennan CaruthersMarch 16, 2012
Next

Pronota announces EUR 3.7 million Series C financing ; management and board changes.

Brennan CaruthersJanuary 20, 2012

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact